🇺🇸 FDA
Patent

US 9463254

Molecular design toward dual-modality probes for radioisotope-based imaging (PET or SPECT) and MRI

granted A61KA61K49/0002A61K49/124

Quick answer

US patent 9463254 (Molecular design toward dual-modality probes for radioisotope-based imaging (PET or SPECT) and MRI) held by The Board of Regents of the University of Texas System expires Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Oct 11 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 06 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61K, A61K49/0002, A61K49/124, A61K49/14, A61K51/065